Checkpoint kinases are critical in cancer because they help prevent the proliferation of cells with damaged DNA, which could otherwise lead to tumorigenesis. In many cancers, the pathways involving checkpoint kinases are disrupted, leading to uncontrolled cell division and tumor growth. For instance, mutations in the p53 gene, a key regulator of the DNA damage response, can impair the function of checkpoint kinases, contributing to cancer development.
